发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| CHINA MAINLAND | 320 |
| USA | 96 |
| England | 14 |
| GERMANY (FED REP GER) | 12 |
| Canada | 10 |
| Australia | 8 |
| Japan | 6 |
| Spain | 6 |
| India | 5 |
| France | 4 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| SICHUAN UNIVERSITY | 47 |
| CHINESE ACADEMY OF SCIENCES | 38 |
| SUN YAT SEN UNIVERSITY | 31 |
| ZHEJIANG UNIVERSITY | 30 |
| FUDAN UNIVERSITY | 29 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING U... | 21 |
| SHANGHAI JIAO TONG UNIVERSITY | 21 |
| ZHENGZHOU UNIVERSITY | 18 |
| COLLABORAT INNOVAT CTR BIOTHERAPY | 17 |
| TONGJI UNIVERSITY | 17 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Controlled drug delivery vehicles for cancer treatment a... | 213 |
| Targeting oncogenic Myc as a strategy for cancer treatme... | 89 |
| The independence of and associations among apoptosis, au... | 67 |
| The emerging treatment landscape of targeted therapy in ... | 61 |
| Targeted therapy in chronic diseases using nanomaterial-... | 57 |
| Targeting epigenetic regulators for cancer therapy: mech... | 53 |
| History and progress of hypotheses and clinical trials f... | 49 |
| PROTACs: great opportunities for academia and industry | 41 |
| Targeting EGFR exon 20 insertion mutations in non-small ... | 39 |
| The intracellular signalosome of PD-L1 in cancer cells | 35 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| INT J MOL SCI | 66 |
| CANCERS | 26 |
| SCI REP-UK | 26 |
| SIGNAL TRANSDUCT TAR | 25 |
| CELLS-BASEL | 21 |
| J RECEPT SIG TRANSD | 19 |
| SEMIN CANCER BIOL | 19 |
| FRONT IMMUNOL | 17 |
| OXID MED CELL LONGEV | 14 |
| FRONT ONCOL | 9 |